Stocks Hitting 52-Week Lows

shares dipped 19.30% to touch a new 52-week low of $6.02. Spectrum Pharma confirmed that the court has ordered a judgment in favor of defendant Sandoz in Fusilev patent litigation. Roth Capital downgraded Spectrum Pharmaceuticals from Buy to Neutral.

shares fell 1.53% to reach a new 52-week low of $3.55. eGain shares have dropped 58.84% over the past 52 weeks, while the S&P 500 index has gained 14.22% in the same period.

shares fell 6.46% to touch a new 52-week low of $21.88. NOW reported Q4 earnings of $0.14 per share on revenue of $1.01 billion.

shares slipped 3.79% to reach a new 52-week low of $12.69. Nomura downgraded Intelsat from Buy to Neutral and lowered the price target from $26.00 to $13.00.